AdministrationAgreement-v3.0(2024EN): verschil tussen versies
Geen bewerkingssamenvatting |
Geen bewerkingssamenvatting |
||
| Regel 8: | Regel 8: | ||
Release<!--hdPublication-->: '''2024''' <br> | Release<!--hdPublication-->: '''2024''' <br> | ||
Release status<!--hdPublicationStatus-->: Published<br> | Release status<!--hdPublicationStatus-->: Published<br> | ||
Release date<!--hdPublicationDate-->: | Release date<!--hdPublicationDate-->: 24-04-2024 | ||
<!-- Aanroep Errata transclude page --> | <!-- Aanroep Errata transclude page --> | ||
{{ErrataEN<!--hdErrata-->|2024|{{PAGENAME}}}} | {{ErrataEN<!--hdErrata-->|2024|{{PAGENAME}}}} | ||
| Regel 50: | Regel 50: | ||
|style="width:250px; "|DCM::Name||nl.zorg.Toedieningsafspraak | |style="width:250px; "|DCM::Name||nl.zorg.Toedieningsafspraak | ||
|- | |- | ||
|style="width:250px; "|DCM::PublicationDate|| | |style="width:250px; "|DCM::PublicationDate||24-04-2024 | ||
|- | |- | ||
|style="width:250px; "|DCM::PublicationStatus||Published | |style="width:250px; "|DCM::PublicationStatus||Published | ||
| Regel 99: | Regel 99: | ||
|- | |- | ||
|style="width:75px; "|[[ZIBIssues500_2#ZIB-1261 | ZIB-1261 ]] | |style="width:75px; "|[[ZIBIssues500_2#ZIB-1261 | ZIB-1261 ]] | ||
| | |Medicatieafspraak waardelijst MedicatieafspraakStopTypeCodelijst bevat vervallen SNOMED CT codes | ||
|- | |- | ||
|style="width:75px; "|[[ZIBIssues500_2#ZIB-1454 | ZIB-1454 ]] | |style="width:75px; "|[[ZIBIssues500_2#ZIB-1454 | ZIB-1454 ]] | ||
| | |Onduidelijkheid codes bij StopType codelijsten | ||
|- | |- | ||
|style="width:75px; "|[[ZIBIssues500_2#ZIB-1457 | ZIB-1457 ]] | |style="width:75px; "|[[ZIBIssues500_2#ZIB-1457 | ZIB-1457 ]] | ||
| | |Verwijderen woord 'voorlopig' | ||
|- | |- | ||
|style="width:75px; "|[[ZIBIssues500_2#ZIB-1468 | ZIB-1468 ]] | |style="width:75px; "|[[ZIBIssues500_2#ZIB-1468 | ZIB-1468 ]] | ||
| | |AdministrationAgreement.supplier verkeerde vertaling | ||
|} | |} | ||
| Regel 115: | Regel 115: | ||
|- | |- | ||
|style="width:75px; "|[[ZIBIssues500_3#ZIB-1685 | ZIB-1685 ]] | |style="width:75px; "|[[ZIBIssues500_3#ZIB-1685 | ZIB-1685 ]] | ||
| | |Medicatiebouwstenen MA, TA, MGB - engelse vertaling van 'tot en met' | ||
|- | |- | ||
|style="width:75px; "|[[ZIBIssues500_3#ZIB-1690 | ZIB-1690 ]] | |style="width:75px; "|[[ZIBIssues500_3#ZIB-1690 | ZIB-1690 ]] | ||
| | |ToedieningsafspraakAanvullendeInformatieCodelijst heeft 'verkeerde' oid voor codesysteem | ||
|- | |- | ||
|style="width:75px; "|[[ZIBIssues500_3#ZIB-1695 | ZIB-1695 ]] | |style="width:75px; "|[[ZIBIssues500_3#ZIB-1695 | ZIB-1695 ]] | ||
| | |Omschrijving van veld 'verstrekker' aanpassen in TA en MVE | ||
|- | |- | ||
|style="width:75px; "|[[ZIBIssues500_3#ZIB-1722 | ZIB-1722 ]] | |style="width:75px; "|[[ZIBIssues500_3#ZIB-1722 | ZIB-1722 ]] | ||
| | |Verzameling errata bouwsteen Toedieningsafspraak | ||
|} | |} | ||
| Regel 131: | Regel 131: | ||
|- | |- | ||
|style="width:75px; "|[[ZIBIssues500_3#ZIB-1771 | ZIB-1771 ]] | |style="width:75px; "|[[ZIBIssues500_3#ZIB-1771 | ZIB-1771 ]] | ||
| | |Wijziging conceptnaam binnen zib Toedieningsafspraak | ||
|- | |- | ||
|style="width:75px; "|[[ZIBIssues500_3#ZIB-1940 | ZIB-1940 ]] | |style="width:75px; "|[[ZIBIssues500_3#ZIB-1940 | ZIB-1940 ]] | ||
| | |RedenWijzigen-StakenCodelijst - SNOMED-term bij 159691000146109 | ||
|} | |} | ||
| Regel 141: | Regel 141: | ||
|- | |- | ||
|style="width:75px; "|[[ZIBIssues500_3#ZIB-1903 | ZIB-1903 ]] | |style="width:75px; "|[[ZIBIssues500_3#ZIB-1903 | ZIB-1903 ]] | ||
| | |"Annuleren" van MA en TA bouwstenen | ||
|- | |- | ||
|style="width:75px; "|[[ZIBIssues500_4#ZIB-2162 | ZIB-2162 ]] | |style="width:75px; "|[[ZIBIssues500_4#ZIB-2162 | ZIB-2162 ]] | ||
| | |Toedieningsafspraak AanvullendeInformatie | ||
|- | |- | ||
|style="width:75px; "|[[ZIBIssues500_4#ZIB-2202 | ZIB-2202 ]] | |style="width:75px; "|[[ZIBIssues500_4#ZIB-2202 | ZIB-2202 ]] | ||
| Regel 164: | Regel 164: | ||
rect 361 76 490 146 [[InstructionsForUse-v3.1(2024EN)]] | rect 361 76 490 146 [[InstructionsForUse-v3.1(2024EN)]] | ||
rect 534 76 663 146 [[MedicationAgreement-v4.0(2024EN)]] | rect 534 76 663 146 [[MedicationAgreement-v4.0(2024EN)]] | ||
rect 711 76 902 146 [[PharmaceuticalProduct-v2. | rect 711 76 902 146 [[PharmaceuticalProduct-v2.3(2024EN)]] | ||
rect 178 76 307 146 [[HealthcareProvider-v3.6(2024EN)]] | rect 178 76 307 146 [[HealthcareProvider-v3.6(2024EN)]] | ||
rect 423 359 583 429 [[#1496]] | rect 423 359 583 429 [[#1496]] | ||
| Regel 231: | Regel 231: | ||
{| | {| | ||
|- | |- | ||
|[[Bestand: block.png | link=PharmaceuticalProduct-v2. | |[[Bestand: block.png | link=PharmaceuticalProduct-v2.3(2024EN)]]||[[PharmaceuticalProduct-v2.3(2024EN) |PharmaceuticalProduct]] | ||
|} | |} | ||
|-style="vertical-align:top; background-color: transparent; " | |-style="vertical-align:top; background-color: transparent; " | ||
| Regel 625: | Regel 625: | ||
*[[InstructionsForUse-v3.1(2024EN)|InstructionsForUse-v3.1]] | *[[InstructionsForUse-v3.1(2024EN)|InstructionsForUse-v3.1]] | ||
*[[MedicationAgreement-v4.0(2024EN)|MedicationAgreement-v4.0]] | *[[MedicationAgreement-v4.0(2024EN)|MedicationAgreement-v4.0]] | ||
*[[PharmaceuticalProduct-v2. | *[[PharmaceuticalProduct-v2.3(2024EN)|PharmaceuticalProduct-v2.3]] | ||
*[[TimeInterval-v1.3(2024EN)|TimeInterval-v1.3]] | *[[TimeInterval-v1.3(2024EN)|TimeInterval-v1.3]] | ||
====This information model is used in<!--ftReferredBy-->==== | ====This information model is used in<!--ftReferredBy-->==== | ||
| Regel 642: | Regel 642: | ||
SNOMED CT and LOINC codes are based on: | SNOMED CT and LOINC codes are based on: | ||
<ul> | <ul> | ||
<li>SNOMED Clinical Terms versie: | <li>SNOMED Clinical Terms versie: 20250430 [R] (april 2025-editie)</li> | ||
<li>LOINC version 2.77</li> | <li>LOINC version 2.77</li> | ||
</ul> | </ul> | ||
Conditions for use are located on the mainpage<!--ftConditions--> [[Bestand:list2.png|link=HCIM_Mainpage<!--wikiMainpage-->]]<BR> | Conditions for use are located on the mainpage<!--ftConditions--> [[Bestand:list2.png|link=HCIM_Mainpage<!--wikiMainpage-->]]<BR> | ||
This page is generated on | This page is generated on 27/05/2025 14:01:18 with ZibExtraction v. 9.5.9242.40707<!--ftDate--> <BR> | ||
----- | ----- | ||
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release<!--wikiReleasePage-->_2024(EN)]] [[HCIM_Release<!--wikiReleasePage-->_2024(EN) |Back to HCIM list<!--hdBackToMainPage--> ]]</div> | <div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release<!--wikiReleasePage-->_2024(EN)]] [[HCIM_Release<!--wikiReleasePage-->_2024(EN) |Back to HCIM list<!--hdBackToMainPage--> ]]</div> | ||
Huidige versie van 27 mei 2025 om 16:55
General information
Name: nl.zorg.AdministrationAgreement ![]()
Version: 3.0
HCIM Status:Final
Release: 2024
Release status: Published
Release date: 24-04-2024
Metadata
| DCM::CoderList | Projectgroep Medicatieproces |
| DCM::ContactInformation.Address | |
| DCM::ContactInformation.Name | * |
| DCM::ContactInformation.Telecom | |
| DCM::ContentAuthorList | Projectgroep Medicatieproces |
| DCM::CreationDate | 1-2-2017 |
| DCM::DeprecatedDate | |
| DCM::DescriptionLanguage | nl |
| DCM::EndorsingAuthority.Address | |
| DCM::EndorsingAuthority.Name | PM |
| DCM::EndorsingAuthority.Telecom | |
| DCM::Id | 2.16.840.1.113883.2.4.3.11.60.40.3.9.8 |
| DCM::KeywordList | Medicatie, Toediening |
| DCM::LifecycleStatus | Final |
| DCM::ModelerList | Architectuurgroep Registratie aan de Bron |
| DCM::Name | nl.zorg.Toedieningsafspraak |
| DCM::PublicationDate | 24-04-2024 |
| DCM::PublicationStatus | Published |
| DCM::ReviewerList | Projectgroep Medicatieproces & Architectuurgroep Registratie aan de Bron |
| DCM::RevisionDate | 10-04-2024 |
| DCM::Supersedes | nl.zorg.Toedieningsafspraak-v2.1 |
| DCM::Version | 3.0 |
| HCIM::PublicationLanguage | EN |
Revision History
Only available in Dutch
Publicatieversie 1.0 (04-09-2017)
Publicatieversie 1.0.1 (31-12-2017)
| ZIB-643 | Kleine tekstuele verbeteringen |
Publicatieversie 1.0.2 (31-01-2020)
| ZIB-888 | terminologie reden voor stoppen medicatie verbeteren en SNOMED coderingen zibs met meditatieproces gelijktrekken |
Publicatieversie 1.0.3 (01-09-2020)
| ZIB-911 | Correction English "Farmaceutical" |
| ZIB-1006 | Typo Toedieningsafspraak stop type: een 'g' teveel |
Publicatieversie 1.1 (01-12-2021)
| ZIB-1261 | Medicatieafspraak waardelijst MedicatieafspraakStopTypeCodelijst bevat vervallen SNOMED CT codes |
| ZIB-1454 | Onduidelijkheid codes bij StopType codelijsten |
| ZIB-1457 | Verwijderen woord 'voorlopig' |
| ZIB-1468 | AdministrationAgreement.supplier verkeerde vertaling |
Publicatieversie 2.0 (10-06-2022)
| ZIB-1685 | Medicatiebouwstenen MA, TA, MGB - engelse vertaling van 'tot en met' |
| ZIB-1690 | ToedieningsafspraakAanvullendeInformatieCodelijst heeft 'verkeerde' oid voor codesysteem |
| ZIB-1695 | Omschrijving van veld 'verstrekker' aanpassen in TA en MVE |
| ZIB-1722 | Verzameling errata bouwsteen Toedieningsafspraak |
Publicatieversie 2.1 (15-10-2023)
| ZIB-1771 | Wijziging conceptnaam binnen zib Toedieningsafspraak |
| ZIB-1940 | RedenWijzigen-StakenCodelijst - SNOMED-term bij 159691000146109 |
Publicatieversie 3.0 (15-04-2024)
| ZIB-1903 | "Annuleren" van MA en TA bouwstenen |
| ZIB-2162 | Toedieningsafspraak AanvullendeInformatie |
| ZIB-2202 | Geen informatie |
Concept
An administration agreement is the use (or administering) instructions from the pharmacist to the patient (or their representative or administrator), whereby a medication agreement is structured at a concrete level.
Purpose
The goal of the administration agreement is to provide insight into the concrete instructions for administration/use of medication.
Information Model

| Type | Id | Concept | Card. | Definition | DefinitionCode | Reference | ||||||||
| NL-CM:9.8.20132 | Root concept of the AdministrationAgreement information model. This root concept contains all data elements of the AdministrationAgreement information model. |
|
||||||||||||
| NL-CM:9.8.22499 | 0..1 | Reason for modification or discontinuation of this agreement. This will often be the same reason as the one for modification or discontinuation of the medication agreement. This field has the option to - if applicable - enter a specific reason for modification or discontinuation of the administration agreement |
|
| ||||||||||
| NL-CM:9.8.22097 | 0..1 | The supplier (healthcare provider) that entered the administration agreement. |
| |||||||||||
| NL-CM:9.8.20237 | 1 | Medicine in the AdministrationAgreement. |
| |||||||||||
| NL-CM:9.8.22098 | 0..1 | Instructions for administering the medication, e.g. dose and route of administration. |
| |||||||||||
| NL-CM:9.8.20133 | 0..1 | The time at which the agreement was made. | ||||||||||||
| NL-CM:9.8.22660 | 1 | Start date: This is the time at which the agreement was to take effect (or took effect or will take effect). This is the time at which the instructions for use in this agreement start. In the case of an agreement to discontinue use, this is the start date of the original administration agreement. The end date indicates from when the medication is to be discontinued.
Duration: The intended duration of use. E.g. 5 days or 8 weeks. It is not allowed to indicate the duration in months, because different months have a variable duration in days.
End date: The time at which the period of use ends (or ended or will end). In the case of an agreement to discontinue use, this is the time at which the medication is to be discontinued. To avoid confusion between 'to' and 'up until and including', the submission of time is always mandatory for the end date. |
| |||||||||||
| NL-CM:9.8.22394 | 0..1 | Relationship to the medication agreement on which the administration agreement is based. |
| |||||||||||
| NL-CM:9.8.22498 | 0..1 | Stop type, the manner in which this medication is discontinued (temporary or definitive). |
| |||||||||||
| NL-CM:9.8.22275 | 0..1 | Comments on the administration agreement. |
|
|||||||||||
Columns Concept and DefinitionCode: hover over the values for more information
For explanation of the symbols, please see the legend page
Example Instances
Only available in Dutch
| ToedieningsAfspraakDatumTijd | Gebruiksperiode | GeneesmiddelBijToedieningsafspraak | Verstrekker | GeannuleerdIndicator | ToedieningsafspraakStoptype | ||
| Ingangsdatum | Einddatum | Duur | ProductCode | Zorgaanbieder | |||
| 2-5-2012 12:14:09 | 02-05-12 | 4 weken | Paracetamol tablet 500 mg | Apotheek De Gulle Gaper | |||
| 10-9-2015 9:16:31 | 5 dagen | Pantoprazol injpdr 40 mg fl | Apotheek De Gulle Gaper | Ja | |||
| 19-9-2014 7:12:59 | 19-09-14 | 18-12-14 | Dalteparine 2500 injvlst 12.500 ie/ml wwsp 0,2ml | Poli-apotheek Het Ziekenhuis | |||
| 30-8-2013 8:41:43 | 01-08-13 | 30-08-13 | Prednison 5 mg | Poli-apotheek Het Ziekenhuis | Definitief |
| Gebruiksinstructie | ||||||
| Omschrijving | ToedieningsWeg | HerhaalperiodeCyclischSchema | Doseerinstructie | |||
| Doseerduur | Dosering|Keerdosis | Toedieningsschema|Frequentie|Interval|Toedientijd|Weekdag|Dagdeel | Zo nodig | |||
| Vanaf 2 mei gedurende 4 weken zo nodig bij pijn 500 mg (=1 st), max. 4x per dag | oraal | 1 | 4 weken | 1 stuk | max. 4x/dag | Bij pijn |
| Gedurende 5 dagen 1x/dag (8u) 40 mg (=1 st) | iv | 40 mg (=1 st) | 1x per dag om 8.00 uur | |||
| Vanaf 19-9-2014 tot 18-12-2014 1x per dag om 18uur 2500ie(=0,2ml) | subcutaan | 2500 IE (=0,2 ml) | 1x per dag om 18.00 uur | |||
| Van 1-8-2013 tot 30-8-2013 volgens afbouwschema. Per 30-8-2013 onderbreken. | oraal | 1 |
Valuesets
AdministrationAgreementReasonModificationOrDiscontinuationCodelist
| Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.9.8.3 | Binding: Extensible | Status: Active |
| Conceptname | Conceptcode | Codesystem name | Codesystem OID | Description |
| Adverse reaction to drug | 62014003 | SNOMED CT | 2.16.840.1.113883.6.96 | Ongewenste reactie op medicatie en/of drugs |
| Administration of medication contraindicated | 438833006 | SNOMED CT | 2.16.840.1.113883.6.96 | Toedienen van medicatie gecontra-indiceerd |
| Medication interaction | 79899007 | SNOMED CT | 2.16.840.1.113883.6.96 | Geneesmiddelinteractie |
| Lack of drug action | 58848006 | SNOMED CT | 2.16.840.1.113883.6.96 | Gebrek aan geneesmiddeleffect |
| Drug action too strong | 112251000146103 | SNOMED CT | 2.16.840.1.113883.6.96 | Te sterk effect van medicatie |
| Insufficient route of drug administration | 112191000146101 | SNOMED CT | 2.16.840.1.113883.6.96 | Medicatietoedieningsweg voldoet niet |
| Drug treatment not indicated | 183966005 | SNOMED CT | 2.16.840.1.113883.6.96 | Geen indicatie voor medicamenteuze behandeling |
| Medication management changed | 112751000146109 | SNOMED CT | 2.16.840.1.113883.6.96 | Medicatiebeleid veranderd |
| Patient requested modification of treatment | 159711000146106 | SNOMED CT | 2.16.840.1.113883.6.96 | Verzoek van zorgafnemer om behandeling te wijzigen |
| Treatment of previous care provider continued | 112261000146100 | SNOMED CT | 2.16.840.1.113883.6.96 | Hervatten van beleid van vorige voorschrijver |
| Admission to establishment | 305335007 | SNOMED CT | 2.16.840.1.113883.6.96 | Opname in instelling |
| Planned procedure | 405613005 | SNOMED CT | 2.16.840.1.113883.6.96 | Verrichting gepland |
| Incorrect registration of medication | 159691000146109 | SNOMED CT | 2.16.840.1.113883.6.96 | Foutieve registratie van medicatie |
| Drug not available - out of stock | 182856006 | SNOMED CT | 2.16.840.1.113883.6.96 | Geneesmiddel niet voorradig |
| Change in laboratory test finding | 160131000146104 | SNOMED CT | 2.16.840.1.113883.6.96 | Verandering in labwaarde |
| Patient-friendly Dutch at B1 reading level language reference set | 160161000146108 | SNOMED CT | 2.16.840.1.113883.6.96 | Dubbele registratie van medicamenteuze behandeling [DEPRECATED] |
| Double registration of medication treatment | 180011000146107 | SNOMED CT | 2.16.840.1.113883.6.96 | Dubbele registratie van medicamenteuze behandeling |
| Patient takes medication as prescribed | 112221000146107 | SNOMED CT | 2.16.840.1.113883.6.96 | Medicatiegebruik van patiënt volgens afspraak |
| Value Other (OTH) from codesystem NullFlavor (OID: 2.16.840.1.113883.5.1008) is allowed in this valueset. | ||||
AdministrationAgreementStopTypeCodeList
| Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.9.8.1 | Binding: Required | Status: Active |
| Conceptname | Conceptcode | Codesystem name | Codesystem OID | Description |
| Drug therapy temporarily stopped | 113381000146106 | SNOMED CT | 2.16.840.1.113883.6.96 | Tijdelijke onderbreking van medicamenteuze behandeling (bijvoorbeeld tijdelijk stoppen gebruik vanwege operatie). [DEPRECATED] |
| Drug therapy definitely stopped | 113371000146109 | SNOMED CT | 2.16.840.1.113883.6.96 | Het staken van een bestaande medicamenteuze behandeling. [DEPRECATED] |
| Discontinued | 410546004 | SNOMED CT | 2.16.840.1.113883.6.96 | Stopgezet |
| Suspended | 385655000 | SNOMED CT | 2.16.840.1.113883.6.96 | Onderbroken |
| Canceled | 89925002 | SNOMED CT | 2.16.840.1.113883.6.96 | Geannuleerd |
| Other values are not allowed | ||||
This information model in other releases
- Release 2017, (Version 1.0.1)
- Prerelease 2018-2, (Version 1.0.1)
- Prerelease 2019-2, (Version 1.0.2)
- Release 2020, (Version 1.0.3)
- Prerelease 2021-2, (Version 1.1)
- Prerelease 2022-1, (Version 2.0)
- Prerelease 2023-1, (Version 2.1)
- Prerelease 2024-1, (Versie 3.0)
Information model references
This information model refers to
- HealthcareProvider-v3.6
- InstructionsForUse-v3.1
- MedicationAgreement-v4.0
- PharmaceuticalProduct-v2.3
- TimeInterval-v1.3
This information model is used in
- --
Technical specifications in HL7v3 CDA and HL7 FHIR
To exchange information based on health and care information models, additional, more technical specifications are required.
Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:
- HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment

- HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR

Downloads
This information model is also available as pdf file
or as spreadsheet
About this information
The information in this wikipage is based on Release 2024
SNOMED CT and LOINC codes are based on:
- SNOMED Clinical Terms versie: 20250430 [R] (april 2025-editie)
- LOINC version 2.77
Conditions for use are located on the mainpage ![]()
This page is generated on 27/05/2025 14:01:18 with ZibExtraction v. 9.5.9242.40707